NIH-funded research NIH-funded research

Investigating how PGI2 affects immune responses in high blood pressure

Official title: PGI2 restrains immunopathogenesis in hypertension

Funded at Trustees of Indiana University · NIH-10993115 · Data updated 2026-11-12

This study is looking at how a substance called PGI2 can help control the immune system's response in people with high blood pressure, with the hope of finding new ways to manage their condition better.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTrustees of Indiana University
NIH-funded
Lab location1 site (Bloomington, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2025
Funding year2025
Award (this year)$248,999
NIH project number5R00HL159594-05
Project IDNIH-10993115 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who are experiencing hypertension.

Less likely to help

Patients with hypertension that is well-controlled or those without any immune-related complications may not benefit from this research.

What this research studies

This research explores the role of PGI2, a metabolite of arachidonic acid, in regulating immune responses related to hypertension. It focuses on how PGI2 can inhibit pro-inflammatory immune cells and promote regulatory immune cells, potentially leading to better blood pressure management. The study involves examining the interactions between immune cells and their impact on blood pressure, aiming to uncover new therapeutic targets for hypertension. Patients may benefit from insights that could lead to novel treatments for managing high blood pressure.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that improve blood pressure control and reduce cardiovascular risks associated with hypertension.

How similar studies have gone: Previous studies have shown that targeting immune responses can influence hypertension, suggesting that this approach may yield promising results.

Where this research is happening

  • Trustees of Indiana University
    Bloomington, United States
    Active

Researchers

  • Principal investigator: Norlander, Allison Elizabeth — Trustees of Indiana University
  • Study coordinator: Norlander, Allison Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.